izpis_h1_title_alt

Effect of humanizing mutations on the stability of the llama single-domain variable region
ID Soler, Miguel A. (Author), ID Medagli, Barbara (Author), ID Wang, Jiewen (Author), ID Oloketuyi, Sandra (Author), ID Bajc, Gregor (Author), ID Huang, He (Author), ID Fortuna, Sara (Author), ID De Marco, Ario (Author)

.pdfPDF - Presentation file, Download (2,00 MB)
MD5: CC41A21EA3660B03A04F9B1BFCAC1F29
URLURL - Source URL, Visit https://www.mdpi.com/2218-273X/11/2/163 This link opens in a new window

Abstract
In vivo clinical applications of nanobodies (VHHs) require molecules that induce minimal immunoresponse and therefore possess sequences as similar as possible to the human VH domain. Although the relative sequence variability in llama nanobodies has been used to identify scaffolds with partially humanized signature, the transformation of the Camelidae hallmarks in the framework2 still represents a major problem. We assessed a set of mutants in silico and experimentally to elucidate what is the contribution of single residues to the VHH stability and how their combinations affect the mutant nanobody stability. We described at molecular level how the interaction among residues belonging to different structural elements enabled a model llama nanobody (C8WT, isolated from a naïve library) to be functional and maintain its stability, despite the analysis of its primary sequence would classify it as aggregation-prone. Five chimeras formed by grafting CDRs isolated from different nanobodies into C8WT scaffold were successfully expressed as soluble proteins and both tested clones preserved their antigen binding specificity. We identified a nanobody with human hallmarks that seems suitable for humanizing selected camelid VHHs by grafting heterologous CDRs in its scaffold and could serve for the preparation of a synthetic library of human-like single domains.

Language:English
Keywords:nanobody framework, modeling, nanobody humanization, CDR grafting
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:BF - Biotechnical Faculty
Publication status:Published
Publication version:Version of Record
Year:2021
Number of pages:13 str.
Numbering:Vol. 11, iss. 2, art. 163
PID:20.500.12556/RUL-134891 This link opens in a new window
UDC:577
ISSN on article:2218-273X
DOI:10.3390/biom11020163 This link opens in a new window
COBISS.SI-ID:48829955 This link opens in a new window
Publication date in RUL:10.02.2022
Views:543
Downloads:117
Metadata:XML RDF-CHPDL DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Biomolecules
Shortened title:Biomolecules
Publisher:MDPI
ISSN:2218-273X
COBISS.SI-ID:519952921 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:01.02.2021

Projects

Funder:Other - Other funder or multiple funders
Funding programme:China, National Key Research and Development Program
Project number:2019YFA0905600

Funder:ARRS - Slovenian Research Agency
Project number:N4-0046
Name:Identifikacija rekombinantnih nanotelesc za imunsko detekcijo eksosomov za diagnozo raka na dojkah

Funder:ARRS - Slovenian Research Agency
Project number:J4-9322
Name:Razvoj reagentov za diagnostično stratificiranje in tarčno zdravljenje raka na dojki na osnovi tekočinskih biopsij

Funder:Other - Other funder or multiple funders
Funding programme:Associazione Italiana per la Ricerca sul Cancro, My First AIRC grant
Project number:18510

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back